Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection

• 主要作者: Bernhard Resch (Author)
• 格式: 圖書
• 出版: Taylor & Francis Group, 2017-09-01T00:00:00Z.
• 主題: article
• 在線閱讀: Connect to this object online.

Respiratory syncytial virus (RSV) accounts for about 20% of all respiratory infections in children below the age of 5 y. It is associated with up to 63% of all acute respiratory infections and up to 81% of all viral lower respiratory tract infections causing hospitalization in infants and young chil...